Identification of two novel mammographic density loci at 6Q25.1

Breast Cancer Research

Volumn 17, Issue 1, 2015, Pages

  Brand, Judith S ^a   Li, Jingmei ^a   Humphreys, Keith ^a   Karlsson, Robert ^a   Eriksson, Mikael ^a   Ivansson, Emma ^a,b   Hall, Per ^a   Czene, Kamila ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Linköping University   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

ADULT; AGE; AGED; AREG GENE; ARTICLE; BODY MASS; BREAST CANCER; BREAST DENSITY; CANCER RISK; CANCER SUSCEPTIBILITY; CCDC170 GENE; CHROMOSOME 6Q; CONTROLLED STUDY; ESR1 GENE; GENE; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TAB2 GENE; ZNF365 GENE; ABNORMALITIES; BREAST TUMOR; CHROMOSOME 6; FEMALE; GENETIC ASSOCIATION STUDY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MAMMARY GLAND; MIDDLE AGED; PATHOLOGY; QUANTITATIVE TRAIT LOCUS;

ADULT; BREAST DENSITY; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; GENETIC ASSOCIATION STUDIES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MAMMARY GLANDS, HUMAN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI;

EID: 84937027053     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-015-0591-2     Document Type: Article

References (45)

1. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227-36.
2. Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med. 2002;347:886-94.
3. Stone J, Dite GS, Gunasekara A, English DR, McCredie MR, Giles GG, et al. The heritability of mammographically dense and nondense breast tissue. Cancer Epidemiol Biomarkers Prev. 2006;15:612-7.
4. Varghese JS, Thompson DJ, Michailidou K, Lindstrom S, Turnbull C, Brown J, et al. Mammographic breast density and breast cancer: evidence of a shared genetic basis. Cancer Res. 2012;72:1478-84.
5. Brand JS, Humphreys K, Thompson DJ, Li J, Eriksson M, Hall P, et al. Volumetric mammographic density: heritability and association with breast cancer susceptibility Loci. J Natl Cancer Inst. 2014;106. doi: 10.1093/jnci/dju334 . Print 2014 Dec
6. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005;6:798-808.
7. Lindstrom S, Vachon CM, Li J, Varghese J, Thompson D, Warren R, et al. Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet. 2011;43:185-7.
8. Lindstrom S, Thompson DJ, Paterson AD, Li J, Gierach GL, Scott C, et al. Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk. Nat Commun. 2014;5:5303.
9. Fernandez-Navarro P, Gonzalez-Neira A, Pita G, Diaz-Uriarte R, Tais Moreno L, Ederra M, et al. Genome-wide association study identifies a novel putative mammographic density locus at 1q12-q21. Int J Cancer. 2015;136:2427-36.
10. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol. 1994;39:1629-38.
11. Highnam R, Brady M, Yaffe M, Karssemeijer N, Harvey J. Robust breast composition measurement - VolparaTM. Lect Notes Comput Sci. 2010;6136:342-9.
12. Brand JS, Czene K, Shepherd JA, Leifland K, Heddson B, Sundbom A, et al. Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment. Cancer Epidemiol Biomarkers Prev. 2014;23:1764-72.
13. Eng A, Gallant Z, Shepherd J, McCormack V, Li J, Dowsett M, et al. Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods. Breast Cancer Res. 2014;16:439. doi: 10.1186/s13058-014-0439-1 .
14. ImageJ: U.S. National Institutes of Health. Bethesda, MD, USA. http://imagej.nih.gov/ij/
15. Sovio U, Li J, Aitken Z, Humphreys K, Czene K, Moss S, et al. Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk. Br J Cancer. 2014;110:1908-16.
16. Li J, Szekely L, Eriksson L, Heddson B, Sundbom A, Czene K, et al. High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer. Breast Cancer Res. 2012;14:R114.
17. Couwenberg AM, Verkooijen HM, Li J, Pijnappel RM, Charaghvandi KR, Hartman M, et al. Assessment of a fully automated, high-throughput mammographic density measurement tool for use with processed digital mammograms. Cancer Causes Control. 2014;25:1037-43.
18. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45:353-61. 361e1-2.
19. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-75.
20. 1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65.
21. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet. 2012;44:955-9.
22. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genome-wide association scans. Bioinformatics. 2010;26:2190-1.
23. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010;26:2336-7.
24. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet. 2007;39:906-13.
25. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet. 2010;11:499-511.
26. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904-9.
27. Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet. 2006;2:e190.
28. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40:D930-4.
29. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57-74.
30. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature. 2011;473:43-9.
31. Long J, Cai Q, Sung H, Shi J, Zhang B, Choi JY, et al. Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet. 2012;8:e1002532.
32. Zheng W, Zhang B, Cai Q, Sung H, Michailidou K, Shi J, et al. Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet. 2013;22:2539-50.
33. Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K, et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell. 2000;5:649-58.
34. Benson JR. Role of transforming growth factor beta in breast carcinogenesis. Lancet Oncol. 2004;5:229-39.
35. Barcellos-Hoff MH, Akhurst RJ. Transforming growth factor-beta in breast cancer: too much, too late. Breast Cancer Res. 2009;11:202.
36. Lee E, Van Den Berg D, Hsu C, Ursin G, Koh WP, Yuan JM, et al. Genetic variation in transforming growth factor beta 1 and mammographic density in Singapore Chinese women. Cancer Res. 2013;73:1876-82.
37. Zhu P, Baek SH, Bourk EM, Ohgi KA, Garcia-Bassets I, Sanjo H, et al. Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell. 2006;124:615-29.
38. Cutrupi S, Reineri S, Panetto A, Grosso E, Caizzi L, Ricci L, et al. Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells. Oncogene. 2012;31:4353-61.
39. Wang Y, He Y, Qin Z, Jiang Y, Jin G, Ma H, et al. Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population. Breast Cancer Res. 2014;16:422.
40. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009;41:324-8.
41. Yang Z, Shen J, Cao Z, Wang B. Association between a novel polymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk. Breast Cancer Res Treat. 2013;139:267-75.
42. Veeraraghavan J, Tan Y, Cao XX, Kim JA, Wang X, Chamness GC, et al. Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers. Nat Commun. 2014;5:4577.
43. Assi V, Warwick J, Cuzick J, Duffy SW. Clinical and epidemiological issues in mammographic density. Nat Rev Clin Oncol. 2011;9:33-40.
44. Cheddad A, Czene K, Eriksson M, Li J, Easton D, Hall P, et al. Area and volumetric density estimation in processed full-field digital mammograms for risk assessment of breast cancer. PLoS One. 2014;9:e110690.
45. Stone J, Thompson DJ, Dos Santos Silva I, Scott C, Tamimi RM, Lindstrom S, et al. Novel associations between common breast cancer susceptibility variants and risk-predicting mammographic density measures. Cancer Res. 2015. doi: 10.1158/0008-5472 .